Status:
COMPLETED
Safety and Performance of Journey II XR Total Knee System
Lead Sponsor:
Smith & Nephew, Inc.
Conditions:
Journey II XR Total Knee System
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to estimate the safety and performance of Journey II XR TKS based on retrospective data.
Eligibility Criteria
Inclusion
- Subject received primary uni- or bi-lateral total knee arthroplasty with the Journey II XR TKS for approved indication;
- The TKA occurred at least 12 weeks prior to enrollment.
Exclusion
- \- None
Key Trial Info
Start Date :
November 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 10 2020
Estimated Enrollment :
683 Patients enrolled
Trial Details
Trial ID
NCT03798847
Start Date
November 1 2018
End Date
September 10 2020
Last Update
July 14 2023
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Orthopedic Institute of the West
Phoenix, Arizona, United States, 85054
2
Rush Copley Orthopaedics
Aurora, Illinois, United States, 60504
3
Jerry Orthopaedic Institute
Port Huron, Michigan, United States, 48060
4
Reno Orthopedic Clinic
Reno, Nevada, United States, 89503